0.7729
前日終値:
$0.775
開ける:
$0.85
24時間の取引高:
14.71M
Relative Volume:
11.82
時価総額:
$74.06M
収益:
-
当期純損益:
$-93.61M
株価収益率:
-0.3663
EPS:
-2.11
ネットキャッシュフロー:
$-71.16M
1週間 パフォーマンス:
+13.65%
1か月 パフォーマンス:
-30.99%
6か月 パフォーマンス:
-36.65%
1年 パフォーマンス:
-38.17%
Immunic Inc Stock (IMUX) Company Profile
IMUX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IMUX
Immunic Inc
|
0.7729 | 65.17M | 0 | -93.61M | -71.16M | -2.11 |
![]()
ONC
Beone Medicines Ltd Adr
|
257.00 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
443.82 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.282 | 41.83M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
85.54 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
483.07 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-25 | 開始されました | William Blair | Outperform |
2024-11-25 | 開始されました | H.C. Wainwright | Buy |
2024-09-09 | 再開されました | Leerink Partners | Outperform |
2024-08-27 | 開始されました | B. Riley Securities | Buy |
2022-10-21 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2022-09-19 | 再開されました | H.C. Wainwright | Buy |
2021-04-15 | 開始されました | Aegis Capital | Buy |
2021-03-24 | 開始されました | JMP Securities | Mkt Outperform |
2020-10-02 | 開始されました | SVB Leerink | Outperform |
2020-08-26 | 開始されました | Piper Sandler | Overweight |
2020-08-07 | 再開されました | ROTH Capital | Buy |
2020-07-20 | 開始されました | BMO Capital Markets | Outperform |
2020-06-05 | 開始されました | Wedbush | Outperform |
2020-05-11 | 開始されました | H.C. Wainwright | Buy |
2020-03-25 | 開始されました | ROTH Capital | Buy |
2019-07-11 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Immunic Inc (IMUX) 最新ニュース
Immunic at Jefferies Conference: Promising MS Drug Insights - Investing.com
Small cap wrap: Midnight Sun Mining, Standard Uranium, Immunic, ReconAfrica... - Proactive Investors
Market movers: Tesla, Verint, PVH, Immunic... - Proactive financial news
Immunic (IMUX) Receives Continued 'Buy' Rating from D. Boral Cap - GuruFocus
Immunic completes patient enrollment in Phase 3 relapsing multiple sclerosis trials - Proactive financial news
Immunic Completes Enrollment in 2 Phase 3 Studies in Relapsing Multiple Sclerosis - marketscreener.com
IMUX: Promising Results of Vidofludimus Calcium in Multiple Sclerosis Treatment | IMUX Stock News - GuruFocus
IMUX Completes Enrollment for Phase 3 Trials in Multiple Scleros - GuruFocus
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS | IMUX S - GuruFocus
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS - Yahoo Finance
Top Executives Make Bold Moves with Major Immunic Stock Purchases! - TipRanks
Immunic Approves Equity Plan Amendment at Annual Meeting - TipRanks
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering | IMUX Stock News - GuruFocus
Immunic Announces Closing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - Longview News-Journal
Immunic raises $65M in public offering to fund clinical trials - Proactive financial news
Immunic to Participate in Investor, Scientific and Industry Conf - GuruFocus
Immunic Showcases Breakthrough MS Drug Data at 6 Major Healthcare Conferences This Month - Stock Titan
Immunic releases June conference schedule - Proactive Investors
Immunic Announces $65 Million Public Offering - TipRanks
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Eastern Progress
Immunic Inc. prices $65 million public offering By Investing.com - Investing.com South Africa
Immunic (NASDAQ:IMUX) Price Target Lowered to $10.00 at D. Boral Capital - Defense World
Immunic (IMUX) Launches $65M Public Offering, Shares Drop - GuruFocus
Immunic Tumbles After Pricing $65 Million Offering of Warrants - marketscreener.com
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Un - GuruFocus
Small cap wrap: Fineqia, Synchronoss, Santacruz Silver, Immunic... - Proactive financial news
Immunic (IMUX) Receives Target Price Adjustment from D. Boral Ca - GuruFocus
Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering - GuruFocus
Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering | IMUX Stock News - GuruFocus
Immunic (IMUX) Launches Public Offering with Warrant Options | I - GuruFocus
Immunic shares fall 12% after pricing of $65 million underwritten public offering to fund trials - Seeking Alpha
Immunic to raise up to $65M in underwritten public offering - Proactive Investors
Immunic (IMUX) Launches Public Offering with Warrant Options | IMUX Stock News - GuruFocus
Immunic Announces Pricing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com
Immunic Inc. prices $65 million public offering - Investing.com
Immunic, Inc. Announces Proposed Public Offering - Longview News-Journal
Immunic Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Investing.com Nigeria
Immunic launches public offering of warrants to fund clinical trials; shares down - MSN
Immunic slides on planned equity raise - TradingView
Immunic (IMUX) Launches Public Offering with Pre-Funded and Warr - GuruFocus
Immunic announces public offering of warrants to fund trials By Investing.com - Investing.com India
Immunic (IMUX) Launches Public Offering with Pre-Funded and Warrants | IMUX Stock News - GuruFocus
Immunic Announces Public Offering to Fund Trials - TipRanks
Biotech Immunic Launches Strategic Public Offering to Advance Inflammatory Disease Pipeline - Stock Titan
Immunic's IMU-856 shows promise as Celiac Disease Awareness Month draws to a close - Proactive Investors
Immunic’s (IMUX) Buy Rating Reiterated at B. Riley - Defense World
Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic F - GuruFocus
Immunic (IMUX) Price Target Lowered by B. Riley Securities | IMU - GuruFocus
Analyst Adjusts Target Price for Immunic (IMUX) Amid Strategic Financing Prospects | IMUX Stock News - GuruFocus
B. Riley Cuts Price Target on Immunic to $5 From $6, Keeps Buy Rating - marketscreener.com
Immunic Inc (IMUX) 財務データ
収益
当期純利益
現金流量
EPS
Immunic Inc (IMUX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
Rudick Richard Alan | Director |
Nov 12 '24 |
Buy |
1.15 |
87,300 |
100,369 |
87,300 |
大文字化:
|
ボリューム (24 時間):